Showing results (1721-1730 of 1,768) with videos related to
Sort By:
Pageof 177
Critical Care (London, England)|July 2, 2016
Early goal-directed therapy in severe sepsis and septic shock: insights and comparisons to ProCESS, ProMISe, and ARISEH Bryant Nguyen, Anja Kathrin Jaehne, Namita Jayaprakash, et al.Heart Rhythm|May 30, 2017
The Tpeak - Tend interval as an electrocardiographic risk marker of arrhythmic and mortality outcomes: A systematic review and meta-analysisGary Tse, Mengqi Gong, Wing Tak Wong, et al.Proceedings of the National Academy of Sciences of the United States of America|June 8, 2018
YES1 amplification is a mechanism of acquired resistance to EGFR inhibitors identified by transposon mutagenesis and clinical genomicsPang-Dian Fan, Giuseppe Narzisi, Anitha D Jayaprakash, et al.Arthritis and Rheumatism|February 2, 2012
Sustained response and prevention of damage progression in patients with neonatal-onset multisystem inflammatory disease treated with anakinra: a cohort study to determine three- and five-year outcomesCailin H Sibley, Nikki Plass, Joseph Snow, et al.Critical Care Medicine|March 3, 2026
Society of Critical Care Medicine Guidelines for the Allocation of Critical Care Resources to Adults During Crisis-Level ShortagesJoseph L Nates, Namita Jayaprakash, Kallirroi Laiya Carayannopoulos, et al.International Journal of Cancer|July 1, 2014
Folate intake and the risk of oral cavity and pharyngeal cancer: a pooled analysis within the International Head and Neck Cancer Epidemiology ConsortiumCarlotta Galeone, Valeria Edefonti, Maria Parpinel, et al.Nucleic Acids Research|August 19, 2020
Investigating the pharmacodynamic durability of GalNAc-siRNA conjugatesChristopher R Brown, Swati Gupta, June Qin, et al.3 Biotech|November 13, 2023
Improvement of bacterial blight resistance of the high yielding, fine-grain, rice variety, Gangavati sona through marker-assisted backcross breedingC A Manoj, B Muralidhara, P S Basavaraj, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|May 13, 2010
Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanismsAkin Akinc, William Querbes, Soma De, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 27, 2021
A Phase I Dose-Escalation Study to Evaluate the Safety and Tolerability of Evofosfamide in Combination with Ipilimumab in Advanced Solid MalignanciesAparna Hegde, Priyamvada Jayaprakash, Coline A Couillault, et al.Pageof 177